Industry Impact Award

Feipeng Xu is a researcher affiliated with the Affiliated Hospital of Guangdong Medical University, China, whose scholarly activities primarily focus on colon cancer research and related oncological investigations. The researcher has contributed to multiple scientific publications indexed in international databases and has demonstrated sustained engagement in clinical and translational cancer studies.[1] Through academic collaborations, publication output, and citation performance, the researcher has established a measurable research presence within oncology-related disciplines.[2] The present article provides a structured academic recognition profile prepared in relation to the International Research Awards on Oncology and Cancer Research.

Abstract

This academic profile presents a structured overview of the research achievements, publication contributions, and scholarly impact associated with Feipeng Xu. The researcher’s scientific activities are centered on colon cancer and oncology-related clinical investigations, with emphasis on evidence-based medical research, disease mechanisms, therapeutic evaluation, and translational applications.[3] Indexed publications, citation performance, and institutional affiliation collectively demonstrate sustained participation in contemporary cancer research initiatives. The profile additionally evaluates the researcher’s suitability for recognition under the Industry Impact Award category associated with the International Research Awards on Oncology and Cancer Research.[4]

Keywords

Colon cancer; Oncology research; Translational medicine; Clinical oncology; Cancer therapeutics; Research impact; Scopus-indexed publications; Academic recognition; Biomedical science; Industry Impact Award.

Introduction

Cancer research remains a critical domain within global biomedical science due to the increasing prevalence and complexity of oncological diseases. Colon cancer, in particular, continues to represent a major public health concern requiring advancements in diagnostics, treatment strategies, and translational research methodologies.[5] Researchers engaged in this field contribute significantly toward understanding molecular mechanisms, therapeutic responses, and patient-centered clinical outcomes.

Feipeng Xu has participated in research activities associated with oncology and colon cancer investigations through scholarly publications and institutional collaborations at the Affiliated Hospital of Guangdong Medical University. The researcher’s publication record and citation metrics indicate measurable academic engagement within the scientific community.[1] Recognition under international research award platforms frequently considers such indicators alongside scientific relevance, interdisciplinary contribution, and publication visibility.

Research Profile

The academic profile of Feipeng Xu reflects involvement in cancer-oriented biomedical research with particular concentration on colon cancer studies. According to indexed author metrics, the researcher has produced 20 documented publications with an h-index of 6 and a citation count exceeding 90 citations within scholarly databases.[1] These indicators suggest moderate but developing research visibility in the oncology domain.

The institutional affiliation with the Affiliated Hospital of Guangdong Medical University further supports engagement in clinical and translational healthcare research environments. Such affiliations are frequently associated with multidisciplinary collaborations involving surgery, oncology, pathology, molecular biology, and therapeutic sciences.[6] The researcher’s publication activities contribute toward ongoing academic discourse related to cancer diagnosis, disease progression, and evidence-based treatment methodologies.

Research Contributions

The research contributions associated with Feipeng Xu primarily involve scientific investigations related to colon cancer and oncology-based clinical studies. Published works demonstrate participation in biomedical analyses addressing tumor biology, therapeutic approaches, prognostic assessment, and translational applications relevant to gastrointestinal oncology.[7]

Research outputs indexed through international databases indicate collaborative participation in peer-reviewed scientific communication. Contributions in this area support broader efforts aimed at improving clinical understanding and management of cancer-related conditions. Academic visibility through citation accumulation further indicates that the published findings have achieved measurable recognition among researchers working in related disciplines.[2]

Publications

Selected scholarly publications associated with Feipeng Xu include research articles and collaborative studies in oncology and colon cancer research fields. Indexed publication records demonstrate engagement with internationally recognized scientific journals and citation databases.[8]

Research Impact

Research impact within academic oncology is commonly evaluated using bibliometric indicators such as publication count, citation performance, research visibility, and collaborative influence. Feipeng Xu’s Scopus-indexed profile reports 20 publications, 98 citations, and an h-index of 6, indicating sustained scholarly engagement and measurable scientific dissemination.[1]

The citation record further reflects that the researcher’s work has been referenced within broader scientific literature, contributing to ongoing discussions in colon cancer research and oncology-related clinical practice. Participation in peer-reviewed scientific communication supports knowledge development and enhances the translational relevance of biomedical findings.[9]

Award Suitability

The Industry Impact Award recognizes researchers whose scientific contributions demonstrate relevance, measurable scholarly activity, and potential influence within applied biomedical or healthcare-related sectors. Based on available academic metrics and publication activities, Feipeng Xu demonstrates several characteristics consistent with the evaluation criteria typically associated with international oncology research awards.[4]

The researcher’s documented publication record, citation metrics, institutional affiliation, and ongoing engagement with colon cancer research collectively indicate meaningful academic participation in oncology-focused scientific advancement. The available evidence supports recognition within a professional academic award framework emphasizing translational relevance, scientific contribution, and research dissemination.[2]

Conclusion

Feipeng Xu represents an emerging contributor within the field of oncology and colon cancer research through sustained scholarly publication activity and measurable citation performance. Affiliation with the Affiliated Hospital of Guangdong Medical University provides an institutional framework supporting biomedical and translational research initiatives.[6] The researcher’s academic profile demonstrates scientific engagement, publication visibility, and professional relevance suitable for consideration within international oncology award platforms, including the Industry Impact Award category.[4]

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• Representative DOI Publication
  
• International Research Awards on Oncology and Cancer Research
  

References

1. Elsevier. (n.d.). Scopus author details: Feipeng Xu, Author ID 57204454325.
   https://www.scopus.com/authid/detail.uri?authorId=57204454325
   
2. ORCID. (n.d.). ORCID profile of Feipeng Xu.
   https://orcid.org/0009-0003-6887-5778
   
3. National Cancer Institute. (2024). Colon Cancer Research Overview.
   https://www.cancer.gov/types/colorectal
   
4. Pencis. (2026). International Research Awards on Oncology and Cancer Research.
   https://oncology.pencis.com/
   
5. World Health Organization. (2024). Cancer Fact Sheets.
   https://www.who.int/news-room/fact-sheets/detail/cancer
   
6. Affiliated Hospital of Guangdong Medical University. (n.d.). Institutional Research and Clinical Programs.
   https://www.gdmu.edu.cn/
   
7. Siegel, R. L., Miller, K. D., & Jemal, A. (2024). Cancer statistics and research trends.
   https://doi.org/10.3322/caac.21820
   
8. Elsevier. (n.d.). Publication indexing and author citation metrics.
   https://www.scopus.com/